Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-stage Adaptive Randomized Controlled Trial of Andrographis Paniculata Extract, Boesenbergia Rotunda Extract, and Standard Treatment in Asymptomatic COVID-19 Patients

NCT05019326 is registered in ClinicalTrials.gov with Mahidol University as lead sponsor.

NCT NCT05019326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05019326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-stage Adaptive Randomized Controlled Trial of Andrographis Paniculata Extract, Boesenbergia Rotunda Extract, and Standard Treatment in Asymptomatic COVID-19 Patients
Lead sponsor
Mahidol University
Phase
Phase 3
Overall status
Unknown status
Start date
August 30, 2021
Completion date
May 30, 2022
Enrollment
3,060 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19